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Abstract: INTRODUCTION: Frozen shoulder (adhesive capsulitis) is a common painful and functionally-
limiting disease affecting around 2% of the population. So far, therapeutic options are limited and often
unsatisfactory. Platelet-rich plasma (PRP) has been used as a treatment option in other orthopedic
diseases since it contains growth factors that stimulate tissue repair. So far, the effect of PRP on frozen
shoulder lacks evidence. We hypothesized that PRP may be valuable in the prophylaxis and treatment of
secondary frozen shoulder due to capsular remodeling. MATERIALS AND METHODS: An experimental
study of an in vivo frozen shoulder model was conducted. Twenty Sprague-Dawley rats underwent surgery
in which the body of the scapula was connected to the humerus with a high-strength suture. Two groups
of 8 weeks survival time were allocated; a treatment group with one intraoperative injection of PRP
into the glenohumeral joint (n = 10) and a control group without PRP (n = 10). The primary outcome
was the structural change in the posterior synovial membrane of the posterior and inferior part of the
glenohumeral joint using a semi-quantitative grading from 0 (lowest) to 3 (highest). RESULTS: The
posterior synovial membrane structural changes were significantly lower in the PRP group (median = 1
[interquartile range (IQR) = 0-1]) compared to controls (median = 2 [IQR = 1-3]) (p = 0.028). There
were no differences for the remaining synovial membrane changes and fibrous capsule responses between
groups. CONCLUSIONS: In this in vivo shoulder contracture model, PRP injections seem to reduce the
histological severity grade of some parts (i.e., posterior synovial membrane changes) of the secondary
frozen shoulder without causing any side effects. It may be considered to investigate this effect further in
future studies as a potential prophylaxis of secondary frozen shoulder (e.g., in operated or immobilized
shoulders) or as a treatment option for patients with frozen shoulder in the early stage.
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Abstract
Introduction Frozen shoulder (adhesive capsulitis) is a common painful and functionally-limiting disease affecting around 
2% of the population. So far, therapeutic options are limited and often unsatisfactory. Platelet-rich plasma (PRP) has been 
used as a treatment option in other orthopedic diseases since it contains growth factors that stimulate tissue repair. So far, 
the effect of PRP on frozen shoulder lacks evidence. We hypothesized that PRP may be valuable in the prophylaxis and 
treatment of secondary frozen shoulder due to capsular remodeling.
Materials and methods An experimental study of an in vivo frozen shoulder model was conducted. Twenty Sprague–Dawley 
rats underwent surgery in which the body of the scapula was connected to the humerus with a high-strength suture. Two 
groups of 8 weeks survival time were allocated; a treatment group with one intraoperative injection of PRP into the gle-
nohumeral joint (n = 10) and a control group without PRP (n = 10). The primary outcome was the structural change in the 
posterior synovial membrane of the posterior and inferior part of the glenohumeral joint using a semi-quantitative grading 
from 0 (lowest) to 3 (highest).
Results The posterior synovial membrane structural changes were significantly lower in the PRP group (median = 1 [inter-
quartile range (IQR) = 0–1]) compared to controls (median = 2 [IQR = 1–3]) (p = 0.028). There were no differences for the 
remaining synovial membrane changes and fibrous capsule responses between groups.
Conclusions In this in vivo shoulder contracture model, PRP injections seem to reduce the histological severity grade of 
some parts (i.e., posterior synovial membrane changes) of the secondary frozen shoulder without causing any side effects. It 
may be considered to investigate this effect further in future studies as a potential prophylaxis of secondary frozen shoulder 
(e.g., in operated or immobilized shoulders) or as a treatment option for patients with frozen shoulder in the early stage.
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Introduction
Frozen shoulder (also named adhesive capsulitis) is 
described as a slow-onset pain close to the insertion of the 
deltoid leading to sleep problems and painful restriction 
of elevation as well as external rotation without relevant 
changes on a conventional radiograph [1, 2]. It is a com-
mon disease affecting around 2% of the population [3] with 
a cumulative incidence of 2.4 per 1000 persons/year [4] 
and a peak incidence between 40–60 years [5]. Although 
it often resolves after 2 years, up to 40% of patients may 
not fully recover. Primary frozen shoulder is mostly idi-
opathic. Secondary frozen shoulder is often accompanied 
with a poorer prognosis and can be caused traumatically 
by fractures and soft-tissue injuries (e.g., rotator cuff tears 
and surgeries) or non-traumatically by impingement, cal-
cific tendonitis, arthritis, and immobilization, which may 
cause inflammation [6] and contraction [7] of the gleno-
humeral joint [5, 8, 9]. Bunker et al. [10] concluded that 
various trigger factors, like minor traumas or injuries from 
surgery in the area around the shoulder, may evoke an 
inflammatory healing response in persons who are predis-
posed to contractures leading to pathological remodeling. 
However, at this point of time the basic pathogenesis of 
frozen shoulder essentially remains unknown.
Clinically, three stages can be observed: “freezing”, 
which includes night pain, active and passive stiffness, 
“frozen”, which shows reduced pain, and “thawing” which 
manifests less stiffness [5]. Most commonly, restrictions of 
external rotation are found due to capsular tightening [11, 
12]. Histologically, inflammation and consecutive fibrosis 
with excessive type III collagen [10] and angiogenesis of 
the capsule and coraco-humeral ligament [13] can be seen. 
The latter is accompanied by a glassy appearance and pain 
in the beginning and fibrosis and stiffness later on [14]. 
The average duration of the disease is around 30 months, 
but it can also extend to more than 3 years [8, 15].
Unfortunately, the effects of the several treatment 
options, such as non-steroidal anti-inflammatory drugs, 
physiotherapy [16], steroid therapy [17], distension 
arthrography [18], manipulation under anesthesia [19], 
arthroscopic capsular release [20], and open surgical 
release [5] are often short-lived and are still controver-
sially discussed in the literature. Since none of these 
treatment options have been clearly shown to be superior, 
further studies are needed in search for an effective preven-
tion and treatment [5, 19, 21].
Platelet-rich plasma (PRP) is a bioactive part of whole 
blood and includes a variety of growth factors, some of 
which are assumed to influence remodeling, thus initiating 
and stimulating tissue repair [22–24]. It likely prevents 
an overwhelming inflammatory reaction by interacting 
with macrophages leading to an improvement of tissue 
healing and regeneration [22]. So far, the use of PRP has 
not been studied extensively in frozen shoulder cases and 
there are, to the best of our knowledge, only a few previ-
ous studies about this subject [25–27]. PRP might have a 
positive impact on the discussed disturbed composition of 
cytokines and growth factors in frozen shoulder.
In this study, we used an established in vivo contrac-
ture model in rats [28, 29] to compare the histological 
outcomes of a treatment group that received intraarticular 
PRP injections intraoperatively as a prophylactic measure 
and a control group without intraoperative PRP injections. 
We hypothesized that PRP may be valuable in prevention of 
frozen shoulder and in the early stages of the condition due 
to its presumed anti-inflammatory effects and the benefits 
described in literature regarding capsular remodeling.
Materials and methods
Ethics statement
Animal housing and all procedures and protocols were 
approved by the Cantonal Veterinary Office, Zurich, Swit-
zerland (license number 279/2014). They were also in 
accordance with Swiss Animal Protection Law and were also 
conform to European Directive 2010/63/EU of the European 
Parliament and of the Council of 22 September 2010 on the 
Protection of Animals Used for Scientific Purposes and to 
the Guide for the Care and Use of Laboratory Animals.
Study design
Twenty-three male Sprague–Dawley rats were obtained 
from a commercial supplier at the age of 12 weeks and were 
housed in groups of 2–3 animals under standardized condi-
tions throughout the study. After an acclimatization period 
of 1 week, 20 rats were assigned randomly to 2 groups and 
underwent surgery to induce secondary frozen shoulder syn-
drome. Rats in the treatment group received one intraopera-
tive injection of PRP into the glenohumeral joint (n = 10), 
rats in the control group had surgery only without injection 
of PRP (n = 10). Three animals were used for PRP extrac-
tion. The animals were sacrificed 8 weeks after the surgery.
Anesthesia and preparation
Anesthesia was induced in a sealed chamber using a mixture 
of 5% isoflurane and oxygen at a flow rate of approximately 
600 ml/minute (ml/min) and was then maintained via a nose 
mask with 2–3% isoflurane and oxygen at a flow rate of 
600 ml/min. After loss of protective reflexes an eye oint-
ment was applied. Then the right shoulder was shaved and 
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disinfected. Each animal received a subcutaneous injection 
of ketamine-hydrochloride (20 mg [mg]/kilogram [kg] body 
weight [BW]) for pain alleviation prior to surgery. After 
preparation, the animal was placed on a warming pad in 
lateral recumbency on the operating table. All animals were 
monitored continuously during the procedure and surgery 
was performed under aseptic conditions.
Surgical technique
The previously described surgical technique by Ochiai et al. 
[29] and Kanno et al. [28] was used. After palpating the sur-
face landmarks on the right shoulder, including the spine of 
the scapula and humerus, a posterior approach was carried 
out. The caudal border of the scapula was dissected with 
minimal elevation of the subscapularis and infraspinatus 
muscles without damaging the glenohumeral joint capsule. 
Subsequently, a 2-0 FiberWire (Arthrex, Naples, United 
states of America [USA]) was used to connect the body of 
the scapula with the humerus, where it was passed around 
and firmly tied. The wound was closed in two layers, using 
5-0 Vicryl for the subcutis and 4-0 Maxon for intracutane-
ous suture.
Platelet‑rich plasma
The preparation and the injections of PRP were done similar 
to the instructions given by Lamplot et al. [30, 31]. Plate-
let-rich plasma from three donor rats was used. Induction 
and maintenance of anesthesia was conducted as described 
above. The anesthetized animal was placed in dorsal recum-
bency, the thorax opened and the animal was euthanized. 
An intracardiac puncture with a 22-gauge needle of the left 
ventricle was performed to draw around 8 milliliters [ml] of 
whole blood that was mixed with 0.25 ml of citrate phos-
phate buffer. Separation of platelets was achieved by cen-
trifugation in conical tubes of 15 ml at 200 g for 20 min 
at + 20° Celsius before the supernatant was centrifuged in 
a new set of conical tubes at 440 g again. After removal 
of the supernatant the precipitated platelets were harvested 
and mixed with the supernatant to reach a concentration of 
1.5 × 109/ml in a Bürkner chamber. The treatment group 
received one intraoperative injection of 10 microliters [μl] 
of PRP (around  109 platelets/ml) into the glenohumeral joint 
prior to wound closure.
Postoperative procedures
Analgesia was provided by subcutaneous applications of 
buprenorphine (0.1 mg/kg BW) every 6 hours during the 
day and by giving buprenorphine orally over the drinking 
water during the night for up to 3 days following surgery. 
All rats were monitored and scored daily for weight loss, 
general appearance, activity, locomotion and wound healing 
for a period of 5 days after surgery and afterward twice a 
week until the end of the experiment. Although a decrease 
of abduction and rotation in the right extremity and shoulder 
was observed, locomotion was not significantly impaired 
and all animals exhibited normal behavior, i.e., grooming or 
social interaction. On the last day of the experiment, 8 weeks 
after surgery, the animals were sacrificed with carbon diox-
ide and the shoulders were harvested and fixed in formalin 
for histological staining.
Histopathology
To prevent damaging the capsule, the shoulders were dis-
sected from the muscles after X-ray control using the X-Ray 
System Model LX-60 Faxitron (Faxitron X-Ray Corpora-
tion, Tucson, USA). Two thirds of the medial scapula and 
the distal part of the humerus were removed so that they 
could be placed in cases for paraffin embedding. Later on, 
the samples were decalcified in 25% Ethylenediaminetet-
raacetic acid [EDTA], pH 7–7.4 for 2 months and after cut-
ting them into two halves through the glenoid, they were put 
in EDTA for another 2 weeks. Afterwards, the samples were 
dehydrated through a series of ascending alcohol concentra-
tions, waxed after defatting in xylene and cast into paraffin-
blocks. The Leica RM2235 microtome (Leica Microsystems 
GmbH, Wetzlar, Germany) was used to cut the blocks into 
2–4 µm paraffin slides. Finally, the slides were de-paraffi-
nized and stained with haematoxylin and eosin (HE).
All 20 slides were evaluated in a double-blinded fash-
ion by one investigator and one independent observer under 
light microscopy. Structural changes characterized by tis-
sue response (hyperemia, edema) and synovial membrane 
remodeling (folding and flattening of the membrane, sever-
ity grade of the atrophy of synovial epithelium and severity 
grade of the fibrosis of the subsynovial tissue layer) were 
evaluated and classified as either weak, moderate or strong 
deviation from the physiological structure. The inflamma-
tory response in the synovial membrane and in the fibrous 
capsule of the posterior and inferior part of the glenohumeral 
joint were additionally tabulated as the outcome variable. 
The scoring criteria (Table  1) were modified based on 
the following studies [10, 13, 14, 32–36] and determined 
according to the histopathological changes within the exam-
ined groups.
Statistics
Statistical analysis was performed using Stata software (Ver-
sion 13.1; StataCorp LLC, College Station, Texas, USA). 
Data are presented as medians and interquartile ranges 
(IQR) due to non-normal distribution. For better overview 
of the semi-quantitative categorical/continuous data, both, 
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the chi-squared and Wilcoxon rank sum tests, are provided. 
For the chi-squared test, weak/modest (grades 0–2) changes/
responses were grouped and compared to a strong (grade 3) 
response.
p values less than 0.05 were considered significant.
Results
Throughout the in vivo phase, there were no clinically vis-
ible postsurgical complications. All animals ambulated in 
the same fashion, exhibiting some mild limping at the begin-
ning of the follow-up phase due to an altered positioning 
anatomy, which disappeared in the course of the follow-up 
period. It was therefore surprising that three fractures of the 
humeral metaphysis in the control group were detected in the 
post mortal radiographic images, which could be described 
histopathologically as an “intra-vitam” process.
The structural changes in the posterior synovial mem-
brane were significantly lower in animals that were treated 
with PRP compared to controls (chi-squared test: p = 0.025; 
Wilcoxon rank sum test: p = 0.028) (Figs.  1 and 2 and 
Tables 2 and 3). There were no significant differences for the 
remaining synovial membrane changes and fibrous capsule 
responses between the two groups. Further details of these 
results are given in the following paragraphs.
Figure 3 and 4 describe the classification of the gleno-
humeral joint into the posterior and the inferior part for 
the histological examination. Histological analysis of the 
affected shoulders revealed the following structural changes 
(Figs. 5, 6, 7 and 8): hyperemia, atrophy of the synovial 
epithelium, flattened synovial folds, edema in the synovial 
membrane, and fibrosis of the sub-synovium as well as 
Table 1  Scoring criteria of histopathological changes in the glenohumeral joint (synovial membrane, fibrous capsule), modified based on the fol-
lowing studies [10, 13, 14, 32–36]
Setting: 5 × -, 10 × -, 20 × -, 40 ×-magnification, haematoxilin-eosin-staining, Leica Digital-Modul-R (DMR), conventional light microscopy
Grading Synovial membrane Fibrous capsule
Structural changes
 None 0 None None
 Weak 1 Hyperemia
Mild synovial epithelium atrophy
Minimally flattened synovial folds (5–30%)
Hyperemia
Angiogenesis (3–7 vessels/visual field (10 ×))
Mild capsular fibrosis (10–20%)
 Moderate 2 Edema
Hyperemia
Moderate synovial epithelium atrophy
Partly flattened synovial folds (40–60%)
Mild-moderate subsynovium fibrosis (20–60%)
Edema
Hyperemia
Angiogenesis (8–12 vessels/visual field (10 ×))
Moderate capsular fibrosis (30–60%)
 Strong 3 Edema
Hyperemia
Severe synovial epithelium atrophy
Mostly flattened synovial folds (70–100%)
Severe subsynovium fibrosis (70–100%)
Edema
Hyperemia
Angiogenesis (> 12 vessels per visual field (10 ×))
Severe capsular fibrosis (70–100%)
Inflammatory response
 None 0 None None
 Weak 1 Scattered/focal appearing inflammatory cells Scattered/focal appearing inflammatory cells
 Moderate 2 Several/multifocal appearing inflammatory cells Several/multifocal appearing inflammatory cells
 Strong 3 Large number of/multifocal confluent inflammatory 
cells
Large number of/multifocal confluent inflammatory 
cells
Fig. 1  Semi-quantitative categorical data display of posterior syno-
vial structural membrane changes in controls and treatment group in 
an in vivo shoulder contracture model (n = 20) (p = 0.025)
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hyperemia, angiogenesis, fibrosis, and edema in the fibrous 
capsule.
There was a weak to moderate inflammatory response 
present in two animals 2/10 (20%; number 2, 3) of the con-
trol group, but this finding was most likely due to fractures 
of the humeral metaphysis. In one animal (number 2 of the 
control group), a weak inflammatory response was found in 
the synovial membrane of both parts of the glenohumeral 
joint and in the fibrous capsule of the posterior part as well 
as a strong response in the inferior part of the glenohumeral 
joint. The other animal (number 3 of the control group) 
developed a weak inflammatory response in the synovial 
membrane of the posterior part of the joint.
One animal 1/10 (10%, number 8) of the PRP treatment 
group formed a weak inflammatory response located in the 
synovial membrane of the posterior part of the glenohumeral 
joint. No further inflammatory cells were present due to the 
secondary frozen shoulder.
The weak to strong structural changes in the synovial 
membrane of the posterior part of the glenohumeral joint 
Fig. 2  Semi-quantitative continuous data display of posterior syno-
vial structural membrane changes in controls and treatment group in 
an in vivo shoulder contracture model (n = 20) (p = 0.028)
Table 2  Semi-quantitative 
categorical data display of 
synovial membrane changes 
and fibrous capsule responses in 
controls (n = 10) and treatment 
group (n = 10) in an in vivo 
shoulder contracture model 
(n = 20)
N number, % percent, PRP platelet-rich plasma, na not applicable since all data were in the first (weak/
moderate) category
*Chi-squared test comparing weak/moderate change/response (grade 0–2) versus strong (grade 3) response
† Significant
Variable Group Change/response p value*
Weak/moderate (0–2) Strong (3)
0 1 2 3
N (%) N (%) N (%) N (%)
Posterior
 Synovial membrane
  Structural change Control 1 (10) 3 (30) 2 (20) 4 (40) 0.025†
PRP 4 (40) 4 (40) 2 (20) 0 (0)
  Inflammatory response Control 8 (80) 2 (20) 0 (0) 0 (0) na
PRP 9 (90) 1 (10) 0 (0) 0 (0)
 Fibrous capsule
  Structural change Control 2 (20) 7 (70) 1 (10) 0 (0) na
PRP 3 (30) 6 (60) 1 (10) 0 (0)
  Inflammatory response Control 9 (90) 1 (10) 0 (0) 0 (0) na
PRP 10 (100) 0 (0) 0 (0) 0 (0)
Inferior
 Synovial membrane
  Structural change Control 2 (20) 6 (60) 1 (10) 1 (10) 0.305
PRP 5 (50) 5 (50) 0 (0) 0 (0)
  Inflammatory response Control 9 (90) 1 (10) 0 (0) 0 (0) na
PRP 10 (100) 0 (0) 0 (0) 0 (0)
 Fibrous capsule
  Structural change Control 4 (40) 5 (50) 1 (10) 0 (0) 0.305
PRP 3 (30) 7 (70) 0 (0) 0 (0)
  Inflammatory response Control 9 (90) 1 (10) 0 (0) 0 (0) 0.305
PRP 10 (100) 0 (0) 0 (0) 0 (0)
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were detected in nine animals 9/10 (90%; number 1, 2, 3, 5, 
6, 7, 8, 9, 10) of the control group in comparison to six ani-
mals 6/10 (60%; number 3, 4, 5, 7, 9, 10) of the PRP treated 
group, where the structural changes were weak to moderate. 
Three animals 3/10 (30%; number 1, 5, 6) in the control 
group and four animals 4/10 (40%; number 3, 5, 9, 10) in 
the treatment group developed weak structural changes in 
this location. In both groups two animals 2/10 (20%, number 
2, 3 in the control group and number 4, 7 in the treatment 
group) were found with moderate changes, respectively. No 
strong structural changes were detected in the synovial mem-
brane of the posterior part of the glenohumeral joint in PRP 
treated group in comparison to the control group, where four 
animals 4/10 (40%; number 7, 8, 9, 10) resulted in strong 
structure changes in this region.
There was no significant difference of the structural 
changes in synovial membrane of the inferior part of the 
glenohumeral joint between the control and the PRP treat-
ment group observed. Six animals 6/10 (60%; number 1, 3, 
4, 5, 7, 9) of the control group and five animals 5/10 (50%; 
number 4, 6, 7, 9, 10) of the treatment group revealed some 
weak structural changes. In the control group one animal 
1/10 (10%; number 8) showed moderate structural changes 
and in another one 1/10 (10%; number 10) strong structural 
changes were detected.
There was no major difference between the control and 
the treatment group regarding the changes in the fibrous 
capsule. One individual animal 1/10 (10%; number 2 in the 
control group and number 8 in the treatment group) from 
both control and PRP treatment groups revealed moderate 
structural changes in the posterior part of the glenohumeral 
joint. Seven animals 7/10 (70%; number 1, 4, 5, 6, 7, 9, 10) 
in the control group and six animals 6/10 (60%; number 1, 
2, 3, 4, 5, 6) in the treatment group developed weak changes 
in this location.
In the inferior part one animal 1/10 (10%; number 2) from 
the control group showed strong structural changes in the 
fibrous capsule. This was interpreted as a result of the frac-
ture of the bone with subsequent instability and increased 
mobility within the joint. 5/10 animals (50%; number 1, 4, 
5, 8, 10) from the control group and 7/10 (70%; number 1, 2, 
3, 4, 5, 6, 8) of the PRP treatment group showed some weak 
structural changes in the fibrous tissue of the inferior part of 
the glenohumeral joint.
Discussion
According to the results of this study, PRP injection into the 
glenohumeral joint prevented strong structural changes in 
the posterior synovial membrane of rats in an in vivo shoul-
der contracture model. There were no clinical side effects 
observed due to PRP. To the knowledge of the authors, this 
Table 3  Semi-quantitative continuous data display of synovial mem-
brane changes and fibrous capsule responses in controls (n = 10) and 
treatment group (n = 10) in an in  vivo shoulder contracture model 
(n = 20)
IQR interquartile range, PRP platelet-rich plasma
*Wilcoxon rank sum test
† Significant
Variable Group p value*
Control PRP
Median (IQR) Median (IQR)
Posterior
 Synovial membrane
  Structural change 2 (1–3) 1 (0–1) 0.028†
  Inflammatory response 0 (0–0) 0 (0–0) 0.542
 Fibrous capsule
  Structural change 1 (1–1) 1 (0–1) 0.687
  Inflammatory response 0 (0–0) 0 (0–0) 0.317
Inferior
 Synovial membrane
  Structural change 1 (1–1) 0 (0–0) 0.089
  Inflammatory response 0 (0–0) 0 (0–0) 0.317
 Fibrous capsule
  Structural change 1 (0–1) 1 (0–1) 0.895
  Inflammatory response 0 (0–0) 0 (0–0) 0.317
Fig. 3  Schematic drawing of the areas under investigation. Spotted 
area represents the posterior part of the glenohumeral joint. Shaded 
area represents the inferior part of the glenohumeral joint
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Fig. 4  a–b Classification of the glenohumeral joint for the histologi-
cal examination into the posterior part. a The control group shows 
an animal with strong structural changes in the synovial membrane 
and weak structural changes in the fibrous capsule without inflam-
matory response. b The platelet-rich plasma (PRP) group depicts an 
animal with weak structural changes in the synovial membrane and 
the fibrous capsule without an inflammatory response. Magnifica-
tion × 125, HE staining. c–d Classification of the glenohumeral joint 
for the histological examination into the inferior part. c The control 
group represents an animal with weak structural changes in the syno-
vial membrane and none structural changes in the fibrous capsule 
without inflammatory response. d The platelet-rich plasma (PRP) 
group presents an animal with none structural changes in the synovial 
membrane and weak structural changes in the fibrous capsule without 
inflammatory response. Magnification × 125, HE staining
Fig. 5  Posterior synovial membrane, control group; animal with 
strong structural changes in the synovial membrane. Arrows: a flat-
tened synovial folds with loss/atrophy of synovial cells, b hyperemia, 
c edema. Magnification × 200, HE staining
Fig. 6  Posterior synovial membrane, PRP group; animal with weak 
structural changes in the synovial membrane. Arrows: a normal syno-
vial folds, b normal synovial cells, c hyperemia. Magnification × 200, 
HE staining
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is the first standardized experimental preclinical study con-
ducted in rats proving a beneficial effect of PRP, probably by 
down regulating the inflammatory responses in this model 
of secondary frozen shoulder.
So far, there is very sparse evidence about the use of 
PRP in frozen shoulder and if so, has mainly been reported 
in clinical studies in humans. One case report by Aslani 
et al. [25] found beneficial results after intraarticular injec-
tion of PRP. This led to satisfactory improvements by 60%, 
100%, and 70% in diurnal pain, night pain, and function, 
respectively. Furthermore, Kothari et al. [26] demonstrated 
a superior treatment effect of PRP in their clinical study in 
which 195 patients with frozen shoulder were treated rand-
omized with a single injection of PRP or a corticosteroid or 
with ultrasonic therapy, each in combination with exercise 
therapy. After 12 weeks, the group receiving the PRP injec-
tion showed significant improvement over corticosteroid and 
ultrasonic therapy in active and passive range of motion, 
pain and function without suffering from any major side 
effects. Moreover, Lin et al. [27] conducted a randomized 
controlled trial with a 6-month follow-up, in which they 
revealed that PRP injections showed a better and longer 
positive effect than injections of a local anaesthetic in the 
treatment of 60 patients with frozen shoulder, each in com-
bination with exercise therapy.
Our findings are in line with the descriptions in other 
studies [35, 36]. As the shoulders were harvested for histo-
logical analysis 8 weeks after surgery, the frozen shoulder 
was no longer in the early stage and there were no inflam-
matory infiltrates. At this point, the synovial membrane was 
no longer hyperplastic, but started to become atrophic and 
began to disappear. The tissue was often strongly vascular-
ized and hyperemic.
As also seen in other shoulder diseases, the posterior 
capsule tends to become tight in frozen shoulder [37]. This 
was also observed in this experimental study in rats and 
could be one reason why significant results were found in the 
posterior capsule in this study. Although the pathogenesis 
of frozen shoulder is not completely understood yet [5], it 
likely involves an inflammatory [38] or fibrotic process [13]. 
It is also assumed that a cytokine modulated inflammatory 
process is followed by a reactive fibrosis [10, 14, 35], which 
is compatible with our findings and would correlate with 
the lengthened clinical process, i.e., the painful start and the 
following stiffness [5, 10, 14]. At the onset of the disease the 
synovium appears hypervascular and hyperplastic [35, 36]. 
Later, type III collagen accumulates in the subsynovium and 
the capsule and causes a fibrosis [35], which we have also 
seen in our specimens.
According to Hand et al. [14], inflammatory infiltrates 
can be found that mainly consist of mast cells, macrophages 
and T cells, whereas Bunker et al. [13, 39] found no immune 
cells apart from a few leukocytes and macrophages in the 
synovium and the area around the blood vessels, which were 
also observed in our samples. Additionally, the tissue was, 
as we have documented too, strongly vascularized. This 
has also been seen macroscopically and matches the pre-
sumption of an inflammatory process [14]. The cell popula-
tion contained mostly proliferating fibroblasts [14] which 
produce type III collagen excessively [10]. Furthermore, 
Bunker et al. [10, 13, 39] reported the presence of myofi-
broblasts, which was also confirmed by Hettrich et al. [40] 
and could be the reason for the capsule contracture. In our 
Fig. 7  Posterior fibrous capsule, control group; animal with weak 
structural changes in the fibrous capsule and strong structural changes 
in the synovial membrane. Arrows: a flattened synovial folds with 
loss/atrophy of synovial cells, b edema, c severe fibrosis. Magnifica-
tion × 50, HE staining
Fig. 8  Posterior fibrous capsule, PRP group; animal with weak struc-
tural changes in the fibrous capsule and no structural changes in the 
synovial membrane. Arrows: a normal synovial folds with normal 
synovial cells, b capsular and subsynovial hyperemia, c edema, d 
mild fibrosis. Magnification × 200, HE staining
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study, myofibroblast identification was not performed and 
thus cannot be confirmed.
The fact that the frozen shoulder model was based on 
immobilization and soft-tissue injury due to the opera-
tion only is a limitation of our study. However, so far, no 
alternative (idiopathic) frozen shoulder models have been 
described to the best of our knowledge [28, 29, 36]. Since 
secondary frozen shoulder can be associated with a poorer 
prognosis than the primary form [5], it is possible that the 
effects of PRP as a treatment in the early stage of primary 
frozen shoulder would be stronger. Although rats have been 
described as the preferred species for this model, because 
the anatomy of their shoulder resembles the human one, the 
function of a rat shoulder might vary compared to a human 
shoulder [28]. Three humeral fractures were found in the 
control group, despite a clinically uneventful, monitored 
course. Histologically, the lesions were estimated to have 
occurred around 5 weeks before the sacrifice, in the earlier 
phase of the study. However, the exact point of time and 
reason remain uncertain. Therefore, radiographs may be rec-
ommended to exclude fractures. As expected, there were no 
side effects monitored during the treatment with PRP [22, 
30]. Lastly, the sample size of this study was rather small, 
but due to the pilot nature sufficient to draw some prelimi-
nary conclusions.
Future studies may consider repeating a similar study 
focusing on the nature of the inflammatory response and the 
role of macrophages, cytokines, MMPs and growth factors 
such as tumor necrosis factor (TNF), transforming growth 
factor (TGF) and platelet-derived growth factor (PDGF). In 
the clinical setting, a randomized controlled trial may be set 
up with intraarticular PRP injections as prophylaxis against 
post-surgical capsular stiffness or shoulder contracture due 
to immobilization.
In conclusion, the rat frozen shoulder model can be con-
sidered as a somewhat feasible and reliable animal model to 
study pathology of the condition and its treatment. The PRP 
injection treatment did not cause any side effects and was 
safe. It seems to reduce the histological severity grade of the 
secondary frozen shoulder-induced alteration in the poste-
rior synovial membrane. Although there were no significant 
differences for the remaining synovial membrane changes 
and fibrous capsule responses between groups, it could be 
contemplated to investigate this effect further in future stud-
ies as a potential prevention of post-operative stiffness and 
treatment option for patients with frozen shoulder in the 
early stage.
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